Next Quarterly Earnings
Thursday, July 30, 2026
CW 31
Pre-Market
In 25 days
Lantheus Holdings is a US-based pharmaceutical company that develops and commercializes innovative diagnostics and therapeutics. The company focuses on medical imaging and radiopharmaceuticals to improve the detection and treatment of cancer and heart disease. Lantheus significantly contributes to patient care worldwide by offering targeted drugs and diagnostic solutions.